2024 In Focus: Predictions From Florence's Top Leaders On Clinical Research Collaboration


Navigating the landscape of clinical research collaboration in 2024 requires a nuanced understanding of evolving dynamics among sites, sponsors, and CROs. In an insightful interview, Florence's leadership—Ryan Jones, CEO; Catherine Gregor, Chief Clinical Trial Officer; Kristin Surdam, Sr. Director, KOL & Strategy; and Mike Wenger, VP of Solutions—delve into the transformative impact of technology on collaboration.

From shaping current dynamics to their expectations for upcoming technological investments, the leaders shed light on crucial industry trends. They candidly discuss barriers they aim to overcome in the coming year, offering a pragmatic perspective on the challenges that lie ahead. This interview not only provides a glimpse into the forward-looking strategies of industry leaders but also serves as a valuable resource for professionals navigating the complex terrain of clinical research collaboration in the evolving landscape of 2024.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader